Skip to main content

EVERGREEN CAPITAL MANAGEMENT LLC

Position in NVO — Novo Nordisk A S

CIK 1260824 Bellevue, WA

Position in NVO

as of Jun 30, 2026 · filed Jul 23, 2026
Position Value
$4,115,504
+$2,506,369 QoQ
Shares Held
85,847
+96.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#245
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 12% Shared 88% None 0%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Derivatives in NVO

reported options exposure · as of Mar 31, 2026
CallValue
$3,675
CallShares
100
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

EVERGREEN CAPITAL MANAGEMENT LLC holds $119,428,715 across 15 Drug Manufacturers - General names. NVO ranks #8 (3.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 NVO
Novo Nordisk A S
This page
85,847 $4,115,504

All Filings in NVO

Export CSV
29 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,115,504 85,847
2026-03-31 $3,675 100
2026-03-31 $1,609,135 43,786
2025-12-31 $5,088 100
2025-12-31 $8,879,882 174,526
2025-09-30 $5,549 100
2025-09-30 $10,677,829 192,428
2025-06-30 $11,826,438 171,348
2025-03-31 $10,512,729 151,393
2024-12-31 $2,727,263 31,705
2024-09-30 $3,519,351 29,557
2024-06-30 $4,183,280 29,307
2024-03-31 $3,543,454 27,597
2023-12-31 $2,839,909 27,452
2023-09-30 $2,524,948 27,765
2023-06-30 $2,214,480 13,684
2023-03-31 $2,132,793 13,402
2022-12-31 $1,628,680 12,034
2022-09-30 $1,230,230 12,348
2022-06-30 $1,331,476 11,949
2022-03-31 $1,156,141 10,411
2021-12-31 $1,091,328 9,744
2021-09-30 $907,294 9,450
2021-06-30 $767,249 9,159
2021-03-31 $581,160 8,620
2020-12-31 $531,279 7,606
2020-09-30 $489,898 7,056
2020-06-30 $445,918 6,810
2020-03-31 $505,800 8,402